RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more
RaySearch Laboratories AB (publ) (RSLBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.013x
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RSLBF) has a cash flow conversion efficiency ratio of -0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-11.60 Million) by net assets ($919.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RaySearch Laboratories AB (publ) - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how RaySearch Laboratories AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
RaySearch Laboratories AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TRUWORTHS INTL RC-00015
F:IUE
|
N/A |
|
EMTEK (Shenzhen) Co. Ltd.
SHE:300938
|
N/A |
|
Chongqing Gas Grp Corp Ltd
SHG:600917
|
0.082x |
|
TeamViewer SE
LSE:0A36
|
N/A |
|
Nanjing Xinlian Electronics Co Ltd
SHE:002546
|
0.035x |
|
Elmos Semiconductor SE
PINK:ELTTF
|
0.017x |
|
Vardhman Textiles Limited
NSE:VTL
|
0.070x |
|
No Va Land Investment Group Corp
VN:NVL
|
0.053x |
Annual Cash Flow Conversion Efficiency for RaySearch Laboratories AB (publ) (2003–2024)
The table below shows the annual cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $876.71 Million | $485.23 Million | 0.553x | -10.75% |
| 2023-12-31 | $735.23 Million | $455.93 Million | 0.620x | +14.22% |
| 2022-12-31 | $657.16 Million | $356.78 Million | 0.543x | +43.23% |
| 2021-12-31 | $628.31 Million | $238.16 Million | 0.379x | -20.61% |
| 2020-12-31 | $694.35 Million | $331.51 Million | 0.477x | +5.21% |
| 2019-12-31 | $705.47 Million | $320.14 Million | 0.454x | +67.17% |
| 2018-12-31 | $657.45 Million | $178.47 Million | 0.271x | +6.84% |
| 2017-12-31 | $580.42 Million | $147.48 Million | 0.254x | -3.24% |
| 2016-12-31 | $460.19 Million | $120.85 Million | 0.263x | -24.70% |
| 2015-12-31 | $319.52 Million | $111.43 Million | 0.349x | +74.49% |
| 2014-12-31 | $251.55 Million | $50.27 Million | 0.200x | +25.60% |
| 2013-12-31 | $196.60 Million | $31.28 Million | 0.159x | -60.42% |
| 2012-12-31 | $217.55 Million | $87.45 Million | 0.402x | +133.57% |
| 2011-12-31 | $196.70 Million | $33.85 Million | 0.172x | -46.06% |
| 2010-12-31 | $196.76 Million | $62.78 Million | 0.319x | +19.87% |
| 2009-12-31 | $184.86 Million | $49.21 Million | 0.266x | +53.75% |
| 2008-12-31 | $150.44 Million | $26.05 Million | 0.173x | -36.96% |
| 2007-12-31 | $137.85 Million | $37.86 Million | 0.275x | +7.77% |
| 2006-12-31 | $118.07 Million | $30.09 Million | 0.255x | -49.60% |
| 2005-12-31 | $81.85 Million | $41.39 Million | 0.506x | +28.56% |
| 2004-12-31 | $32.72 Million | $12.87 Million | 0.393x | +11.83% |
| 2003-12-31 | $19.82 Million | $6.97 Million | 0.352x | -- |